Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Zystor logo — A privately-held biotechnology company pioneering enzyme rep...

Zystor

A privately-held biotechnology company pioneering enzyme replacement therapies to treat lysosomal storage diseases.

Founded 2004 Series A Total: $8.50M Biotechnology, Health Care +1

General Information

Company Name Zystor
Founded Year 2004
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series A
Social

Get notified when Zystor moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Zystor

Zystor is a pioneering biotechnology startup established in 2004 with a focus on developing enzyme replacement therapies for lysosomal storage diseases. The company has received a notable $8.50M Series A investment on 16 December 2004, attracting investment from a diverse group of notable investors including Stonehenge Capital Company, Apjohn Ventures, Mason Wells, Prolog Ventures, State of Wisconsin Investment Board, Hexagon Investments, Venture Investors. Zystor's commitment to revolutionizing the treatment of debilitating diseases places it at the forefront of the biotechnology and health care industries. With a clear mission and a strong backing from a mix of prominent investors, Zystor holds promise as a potential game-changer in the biotechnology field.

Taxonomy: enzyme replacement therapies, lysosomal storage diseases, drug development, pharmaceuticals

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 7
Investor Investor Investor Investor Investor Investor Investor
16 Dec 2004

FAQ About Zystor

A privately-held biotechnology company pioneering enzyme replacement therapies to treat lysosomal storage diseases.
Zystor was founded in 2004.
Zystor operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Zystor has completed 1 funding round, raising a total of $8.50M. The latest funding stage is Series A.

We're actively collecting intelligence on Zystor.

Track Zystor to get notified

Don't just browse. Track.

Signal Tracker monitors Zystor and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy